Ingenta buys FirstAida stake in staged £2.3 million AI deal

Ingenta PLC has acquired an initial 24.9% stake in FirstAida Limited, an early-stage developer of artificial intelligence software for investigating intellectual property infringement.

The deal gives Ingenta the option to acquire the remaining 75.1% between nine and 15 months after the initial transaction. That next step is linked to FirstAida achieving at least £375,000 of annualised recurring revenue, although Ingenta can waive the condition.

Maximum consideration is approximately £2.3 million, based on Ingenta's share price immediately before the announcement. The consideration is being paid in Ingenta shares rather than cash.

Alongside the acquisition, FirstAida founder Dr Dan Brown has joined Ingenta's board as a Non-Executive Director with immediate effect.

The FirstAida deal at a glance

Item	Detail
Initial stake acquired	24.9%
Initial stake valuation	Approximately £0.5 million
Initial consideration	798,061 Ingenta shares
Option over remaining stake	75.1%
Remaining stake valuation	Approximately £1.2 million
Revenue condition for full ownership	£375,000 annualised recurring revenue
Maximum deferred consideration	Approximately £0.6 million
Maximum total consideration	Approximately £2.3 million
Maximum consideration shares	3,631,937

The initial consideration consists of 587,930 existing Ingenta shares held in treasury and 210,131 newly issued shares.

If Ingenta exercises its option to acquire the remaining stake, it will issue another 1,958,876 shares. Up to 875,000 additional shares could then be issued as deferred consideration, depending on FirstAida's contracted revenue.

The initial and remaining stakes together are valued at approximately £1.8 million. Maximum consideration, including the revenue-linked deferred element, would be equivalent to 1.5 times FirstAida's contracted revenue at that point.

Full terms are available in the original company announcement.

Why FirstAida fits Ingenta's existing business

Ingenta provides software and services to publishing and media companies. Its existing Folio and Conchord products help customers manage contracts, rights, sales, royalties and payments to intellectual property owners.

FirstAida adds something Ingenta does not currently provide: software designed to investigate potential intellectual property abuse.

Its technology is intended to help identify illegal copying, unauthorised redistribution and the use of protected content to train third-party AI systems without permission. It is targeting smaller and mid-sized rights holders and their legal advisers across publishing, standards and patents, music and gaming.

That customer overlap is the strategic attraction. Ingenta believes it can offer FirstAida's services to its established customer base, creating cross-selling opportunities without moving too far away from its existing specialism.

FirstAida also provides AI-based support to legal firms and their clients, including contract management and the assessment of judgments and damages.

The staged structure reduces some acquisition risk

FirstAida is an early-stage business with minimal current revenue. Its main asset is its agentic AI software, meaning systems designed to complete multi-step tasks with a degree of autonomy.

Revenue generation is expected to begin during the second half of 2026. This makes the acquisition strategically interesting but commercially unproven.

Ingenta has therefore avoided committing to full ownership immediately. Its unilateral option to buy the remaining 75.1% is linked to FirstAida reaching at least £375,000 in annualised recurring revenue over the next 15 months.

Recurring revenue is income expected to repeat under subscriptions or ongoing customer contracts. It can provide better visibility than one-off software sales, but FirstAida has yet to demonstrate that it can build this revenue base at scale.

The deferred consideration adds another performance link. Six months after Ingenta exercises its option, it will issue 175,000 shares for each £200,000 by which contracted revenue exceeds £500,000, subject to a maximum of 875,000 shares.

This structure gives Ingenta exposure to FirstAida's potential while making a meaningful portion of the price dependent on commercial progress.

Share issuance is the main financial trade-off

The acquisition does not require Ingenta to make a large initial cash payment. That protects cash resources, but shareholders need to consider dilution from the issue and transfer of shares.

Following the initial transaction, Ingenta will have 15,308,256 shares and voting rights in issue, with no shares remaining in treasury.

If the remaining and maximum deferred consideration shares are issued, a further 2,833,876 new shares would be added. Based on the disclosed figures, this would take the total to 18,142,132 shares.

The maximum number of shares used as consideration across the full transaction is 3,631,937. This comprises 587,930 shares transferred from treasury and 3,044,007 newly issued shares. All consideration shares will be subject to lock-in arrangements.

Investors will therefore need FirstAida's eventual contribution to justify the larger share count. The attraction is that Ingenta is paying with equity and linking later stages to revenue. The risk is that shareholders still face dilution if the option is exercised, while the acquired business remains relatively young.

Dr Dan Brown joins the board

FirstAida founder Dr Dan Brown has joined Ingenta as a Non-Executive Director. He is also Entrepreneur in Residence at University College London's Computer Science department and previously founded SaaS software provider Meganexus, which was acquired by NEC in January 2026.

Ingenta expects his experience in building software businesses and applying AI to intellectual property issues to support both FirstAida's development and the wider group.

Dr Brown will receive annual fees of £40,000. Following the initial consideration share issue, he will have a total beneficial interest in 1,541,345 Ingenta shares, representing approximately 10.1% of voting rights.

His significant shareholding aligns him with the performance of the enlarged group, although investors should also note his position as FirstAida's founder and the ultimate owner of its previous sole shareholder.

What investors should watch next

The next important test is customer traction. FirstAida needs to turn its technology into recurring contracted revenue, with £375,000 serving as the key condition attached to Ingenta's route to full ownership.

Investors should also monitor:

• FirstAida's progress towards generating revenue in the second half of 2026
• Whether Ingenta exercises its option over the remaining 75.1%
• Contracted revenue and any resulting deferred share consideration
• Evidence of cross-selling to Ingenta's existing customers
• Costs required to scale FirstAida's UK and Pune operations

Dr Brown has arranged up to £400,000 of interest-free, non-recourse loans to fund FirstAida's working capital. These would cease to be repayable to him if Ingenta acquires the remaining shares. Further loans of up to £400,000 may be provided on an interest-bearing, repayable basis by mutual agreement.

Ingenta plans to publish its unaudited results for the six months ended 30 June 2026 on 23 September 2026, when it will also provide a further FirstAida update. Investors can compare the acquisition with Ingenta's previous operational progress in this review of its EBITDA growth and dividend increase.

A logical AI extension, but execution now matters

FirstAida appears closely aligned with Ingenta's rights-management products and customer base. The staged consideration is also sensible given that the target currently has minimal revenue.

However, this is not yet an earnings-led acquisition. Its value depends on FirstAida securing customers, building recurring revenue and proving that rights holders will pay for AI-assisted infringement investigation.

The strategic logic is reasonably clear. The commercial evidence is the part still to come.